Exencial Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Exencial Wealth Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.2M	Sell	41,920 -1,540	-4%	-$359K	0.32%	83
2025 Q4	$8.99M	Sell	43,460 -386	-0.9%	-$76.3K	0.28%	97
2025 Q3	$8.13M	Sell	43,846 -8,232	-16%	-$1.41M	0.26%	106
2025 Q2	$7.95M	Buy	52,078 +10,264	+25%	+$1.58M	0.28%	101
2025 Q1	$6.93M	Sell	41,814 -2,759	-6%	-$432K	0.26%	115
2024 Q4	$6.45M	Buy	44,573 +1,000	+2%	+$155K	0.24%	118
2024 Q3	$7.06M	Sell	43,573 -1,548	-3%	-$247K	0.25%	112
2024 Q2	$6.59M	Sell	45,121 -1,842	-4%	-$274K	0.25%	113
2024 Q1	$7.43M	Sell	46,963 -1,642	-3%	-$261K	0.28%	106
2023 Q4	$7.62M	Buy	48,605 +2,991	+7%	+$459K	0.31%	99
2023 Q3	$7.1M	Sell	45,614 -3,392	-7%	-$560K	0.34%	88
2023 Q2	$8.11M	Buy	49,006 +3,558	+8%	+$574K	0.37%	82
2023 Q1	$7.04M	Sell	45,448 -492	-1%	-$79.4K	0.36%	80
2022 Q4	$8.12M	Buy	45,940 +4,629	+11%	+$799K	0.44%	72
2022 Q3	$6.75M	Buy	41,311 +281	+0.7%	+$47.6K	0.41%	78
2022 Q2	$7.28M	Buy	41,030 +1,279	+3%	+$228K	0.41%	79
2022 Q1	$7.04M	Sell	39,751 -4,457	-10%	-$758K	0.35%	96
2021 Q4	$7.56M	Sell	44,208 -8,758	-17%	-$1.43M	0.37%	100
2021 Q3	$8.55M	Buy	52,966 +11,382	+27%	+$1.94M	0.37%	74
2021 Q2	$6.85M	Sell	41,584 -4,173	-9%	-$691K	0.37%	92
2021 Q1	$7.52M	Buy	45,757 +1,720	+4%	+$278K	0.45%	76
2020 Q4	$6.93M	Sell	44,037 -26,409	-37%	-$3.9M	0.47%	76
2020 Q3	$10.5M	Buy	70,446 +23,888	+51%	+$3.53M	0.56%	48
2020 Q2	$6.55M	Buy	46,558 +25,054	+117%	+$3.65M	0.57%	51
2020 Q1	$2.82M	Sell	21,504 -1,091	-5%	-$155K	0.5%	70
2019 Q4	$3.3M	Sell	22,595 -624	-3%	-$84.6K	0.57%	69
2019 Q3	$3M	Sell	23,219 -1,505	-6%	-$198K	0.65%	62
2019 Q2	$3.44M	Hold	24,724	–	–	0.8%	48
2019 Q1	$3.46M	Sell	24,724 -237	-0.9%	-$31.7K	0.82%	46
2018 Q4	$3.22M	Sell	24,961 -774	-3%	-$108K	0.86%	40
2018 Q3	$3.56M	Sell	25,735 -86	-0.3%	-$11.4K	0.83%	42
2018 Q2	$3.13M	Buy	25,821 +1,806	+8%	+$225K	0.87%	47
2018 Q1	$3.08M	Sell	24,015 -786	-3%	-$106K	0.92%	43
2017 Q4	$3.46M	Sell	24,801 -640	-3%	-$89.1K	1.04%	32
2017 Q3	$3.31M	Buy	25,441 +11,889	+88%	+$1.58M	1.09%	33
2017 Q2	$1.79M	Sell	13,552 -72	-0.5%	-$9.19K	0.73%	47
2017 Q1	$1.65M	Sell	13,624 -720	-5%	-$86K	0.72%	47
2016 Q4	$1.65M	Sell	14,344 -112	-0.8%	-$12.9K	0.7%	48
2016 Q3	$1.68M	Buy	14,456 +359	+3%	+$43.6K	0.74%	46
2016 Q2	$1.71M	Buy	14,097 +2,013	+17%	+$229K	0.77%	51
2016 Q1	$1.31M	Buy	12,084 +4,267	+55%	+$442K	0.62%	55
2015 Q4	$763K	Buy	7,817 +241	+3%	+$24.2K	0.38%	70
2015 Q3	$707K	Buy	7,576 +225	+3%	+$21.8K	0.35%	72
2015 Q2	$737K	Sell	7,351 -78	-1%	-$7.81K	0.47%	56
2015 Q1	$741K	Buy	7,429 +5	+0.1%	+$508	0.31%	83
2014 Q4	$779K	Sell	7,424 -66	-0.9%	-$6.96K	0.35%	79
2014 Q3	$798K	Buy	7,490 +4	+0.1%	+$415	0.35%	76
2014 Q2	$794K	Buy	7,486 +25	+0.3%	+$2.53K	0.34%	83
2014 Q1	$737K	Buy	7,461 +22	+0.3%	+$2.04K	0.31%	89
2013 Q4	$702K	Buy	7,439 +36	+0.5%	+$3.32K	0.32%	83
2013 Q3	$687K	Sell	7,403 -107	-1%	-$9.6K	0.32%	85
2013 Q2	$698K	Buy	+7,510	New	+$637K	0.35%	80

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Exencial Wealth Advisors's JNJ Position: Q1 2026 in Review

Exencial Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 3.5% in Q1 2026, selling an estimated $359K and leaving 41,920 shares worth $10.2M. The position accounts for 0.32% of the portfolio, ranked #83.

Exencial Wealth Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.5M in Q3 2020. 4,642 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Exencial Wealth Advisors held 41,920 shares of Johnson & Johnson worth $10.2M as of Q1 2026.
Exencial Wealth Advisors sold 1,540 Johnson & Johnson shares in Q1 2026, an estimated $359K.
Johnson & Johnson made up 0.32% of Exencial Wealth Advisors's portfolio in Q1 2026, its #83 holding.
Exencial Wealth Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
Exencial Wealth Advisors's Johnson & Johnson position peaked at $10.5M in Q3 2020.
4,642 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.